Next Generation Sequencing (NGS) Market Trend Analysis,
Latest Revenue Figures, Growth Insights and Forecast to 2030

Next Generation Sequencing (NGS) Market
Report 2025 by Delvens offers comprehensive market insights, empowering
businesses with a competitive edge. It includes detailed estimates for numerous
segments and sub-segments, providing valuable strategic guidance, Next
Generation Sequencing (NGS) market size was estimated at USD 11.59 billion in
2023 and is projected to reach USD 29.84 billion in 2030 at a CAGR of 14.47%
during the forecast period to 2030.

Get Free Sample
Report@ https://www.delvens.com/get-free-sample/next-generation-sequencing-ngs-market

Next-generation sequencing (NGS) is a massively parallel
sequencing method that offers scalability, high throughput, and high speed for
genome-wide sequencing of nucleotides. Because it involves the preparation of
material for the subsequent sequencing reaction, DNA presequencing is one of
the most important processes in a common sequencing protocol.

Globally, NGS is increasingly integrated into clinical
laboratory analysis, testing and disease diagnosis in the healthcare industry.
In pharmacogenomics, next-generation sequencing (NGS) is often used to
accelerate the drug discovery process.

Recent Developments

·       
In January, 2023, QIAGEN announced a strategic
partnership with California-based population genomics leader Helix to advance
next-generation sequencing companion diagnostics in hereditary diseases.

·       
In March, 2023, The company SOPHiA GENETICS
announced a new partnership with Qiagen that will pair QIAseq reagent technology
with the DDM platform to enhance tumor analysis through next-generation
sequencing (NGS).

Competitive Landscape:
Next Generation Sequencing (NGS) market

·       
10X Genomics

·       
Agilent Technologies

·       
BGI Group

·       
Bio-Rad Laboratories Inc.

·       
Brooks Automation Inc.

·       
CD Genomics

·       
DNASTAR Inc.

·       
Psomagen

·       
Qiagen

·       
Takara Bio

·       
Tecan Trading Group

·       
Thermo Fisher Scientific Inc.

·       
Zymo Research and More

Next Generation
Sequencing (NGS) Market Segmentations:

By Product

·       
Consumables

·       
Sample Preparation Consumables

·       
DNA Fragmentation, End Repair, A-

·       
Tailing and Size Selection

By Application

·       
Diagnostics

·       
Personalized Medicine

·       
Agriculture and Animal Research

·       
Other Applications

By Technology

·       
Sequencing by Synthesis

·       
lon Semiconductor Sequencing

·       
Sequencing by Ligation

·       
Other Technologies

By End User

·       
Academic and Research Centers

·       
Pharmaceutical and Biotechnology

·       
Hospitals and Clinics

·       
Other End Users

Regional Level Scope

·       
North America,

·       
Europe,

·       
Asia-Pacific,

·       
South America, and

·       
Middle East, and Africa

Access Full Report@ https://www.delvens.com/report/next-generation-sequencing-ngs-market

In addition to the
market data for the Next Generation Sequencing (NGS) market, Delvens offers
client-centric reports customized according to the company’s specific demand
and requirements.

Browse More Reports
from Delvens:

Assisted Living (AL) market

Congenital Heart Disease (CHD) market

Periodontal Disease Treatment market

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.

Contact us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-3290-6466

+1 214-377-1144

sales@delvens.com